MDMA
US FDA refuses to approve MDMA for PTSD therapy – now what?
Posted in Medicine, Science on 27th Aug, 2024
by Alex Muller
Despite showing promise for treating PTSD, MDMA-assisted therapy faces significant regulatory, ethical, and financial hurdles, highlighting challenges in accessibility and widespread adoption.
Impressive long-term benefits of MDMA for treating PTSD, study reports
Posted in Medicine on 11th Jun, 2020
by Alex Muller
At the original end-point of the trials, 56 percent of the cohort no longer met the clinical criteria for PTSD. The long-term follow-up data revealed continued improvements in most subjects for well over a year, with 67 percent of the cohort subsequently no longer meeting the PTSD criteria.
MDMA therapy achieves astounding 76% success rate for treating PTSD
Posted in Medicine on 3rd Nov, 2018
by Alex Muller
Phase 2 trials of MDMA-assisted psychotherapy have proven extremely successful; FDA-treatment approval expected by 2021.
MDMA could help autistic people with their social anxiety, according to a new study
Posted in Medicine on 2nd Oct, 2018
by Alex Muller
A small new study has shown how MDMA could help reduce social anxiety in people with autism.
Bitcoin Could Bankroll MDMA Into the Mainstream as a Therapy Drug
Posted in Science on 15th Jan, 2018
by Alex Muller
If funding arrives and all goes to plan, its expected that the U.S. Food and Drug Administration will give MDMA-assisted therapy its stamp of approval by 2021.